Skip to main content

Table 1 Baseline demographic characteristics of participants

From: Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial

 

3-5 years (n=70)

6-11 years (n=70)

12-17years (n=100)

3-17 years (n=240)

Age (years)

 Mean (SD)

4.4(0.7)

8.7(1.4)

13.9(1.3)

9.6(4.2)

 Median (IQR)

4.0(4.0,5.0)

9.0(8.0,10.0)

14.0(13.0,15.0)

10.0(5.0,13.0)

 Min-Max

3.0-5.0

6.0-11.0

12.0-17.0

3.0-17.0

Height (cm)

 Mean (SD)

110.8(5.9)

135.0(11.0)

164.2(9.0)

140.1(24.1)

 Median (IQR)

111.3(107.0,114.5)

136.0(128.0,141.0)

163.5(157.5,171.0)

139.3(115.0,161.0)

 Min-Max

98.5-124.0

108.0-160.0

141.0-186.0

98.5-186.0

Weight (kg)

 Mean (SD)

18.3(2.2)

31.4(10.1)

54.6(12.7)

37.2(18.4)

 Median (IQR)

17.8(16.9,19.4)

28.5(25.1,35.1)

52.6(46.7,59.7)

32.5(20.1,51.2)

 Min-Max

13.5-27.4

17.5-73.9

28.8-94.5

13.5-94.5

Gender

 Male

36(51.4)

32(45.7)

58(58.0)

126(52.5)

 Female

34(48.6)

38(54.3)

42(42.0)

114(47.5)

Ethnicity

 Han Chinese

68(97.1%)

69(98.6%)

99(99.0%)

236(98.3%)

 Other

2(2.9%)

1(1.4%)

1(1.0%)

4(1.7%)